|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310.60 DKK | +1.32% |
|
+5.11% | -4.50% |
| 13/02 | Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows | RE |
| 13/02 | Novo Nordisk's Wegovy Tablet Reaches 38,000 New Prescriptions in the US | FW |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | - | 22 | ||||||
| - | 27 | ||||||
| - | 24 | ||||||
| - | 27 | ||||||
| - | 20 | ||||||
| - | 21 | ||||||
| - | 21 | ||||||
| - | 26 | ||||||
| - | 27 | ||||||
| - | 26 | ||||||
| - | 24 | ||||||
| - | 26 | ||||||
| - | 23 | ||||||
| - | 20 | ||||||
| - | 23 | ||||||
| - | 15 | ||||||
| - | 15 | ||||||
| - | 17 | ||||||
| - | 20 | ||||||
| - | 16 | ||||||
| Average | 22 | |||||||
| Weighted average by Cap. | 24 |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition